EMERYVILLE, Calif., May 3, 2022
/PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic
biotechnology company accelerating the world's transition to
sustainable consumption through its Lab-to-Market™ technology
platform, today announced that it will issue its financial results
for the first quarter ended March 31,
2022, on the morning of Tuesday, May
10, 2022, prior to the opening of the financial markets.
The company will hold a conference call and webcast at
6:00 a.m. Pacific Time (9:00 a.m. Eastern Time), during which,
John Melo, President and Chief
Executive Officer, and Han
Kieftenbeld, Chief Financial Officer, will discuss Amyris'
financial results and provide an update on the company's business.
Participants may access the live webcast on Amyris' Investor
Relations website, where it will be archived for 90 days. The live
call can be accessed by dialing (844) 850-0551 (domestic) or (412)
902-4203 (international) and asking to join the Amyris, Inc.
Amyris (Nasdaq: AMRS) is a leading synthetic biotechnology
company, transitioning the Clean Health & Beauty and Flavors
& Fragrances markets to sustainable ingredients through
fermentation and the company's proprietary Lab-to-Market™
technology platform. This Amyris platform leverages
state-of-the-art machine learning, robotics and artificial
intelligence, enabling the company to rapidly bring new innovation
to market at commercial scale. Amyris ingredients are included in
over 20,000 products from the world's top brands, reaching more
than 300 million consumers. Amyris also owns and operates a family
of consumer brands that is constantly evolving to meet the growing
demand for sustainable, effective and accessible products. For more
information, please visit http://www.amyris.com.
Amyris, the Amyris logo and Lab-to-Market are trademarks or
registered trademarks of Amyris, Inc. in the U.S. and/or other
SOURCE Amyris, Inc.